Released : Apr 24, 2014

24 April 2013

Tiziana Life Sciences PLC 
(the "Company")

First Day of Dealings

Tiziana Life Sciences PLC announces that it has joined the AIM market of the London Stock Exchange and dealings on AIM in its ordinary shares commenced today at 8:00 a.m. under the ticker symbol "TILS".

The Company has issued 16,666,667 ordinary shares at a price of 12p per share pursuant to a placing with new investors.

Gabriele Cerrone, Executive Chairman of the Company, said: "The successful completion of this transaction and our strengthened balance sheet will allow us to build on our pre-clinical success to date and generate shareholder value by continuing to progress our promising Bcl-3 candidate into phase I clinical trials. Furthermore, we now have the capital required to explore further avenues to widen our product and service offerings through product licensing, collaborations and corporate activity."

Enquiries

Tiziana Life Sciences PLC Philip Boyd	www.tizianalifesciences.com +44 20 7493 2853
Cairn Financial Advisers LLP Nominated Adviser Liam Murray / Avi Robinson	+44 20 7148 7900
Beaufort Securities Limited  Broker Saif Janjua	+44 20 7382 8300
FTI Consulting Limited Public Relations  John Dineen / Julia Phillips	+44 20 7831 3113

 

---

 

This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Tiziana Life Sciences PLC via Globenewswire

HUG#1779587